Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123939) titled 'A Clinical Trial of Non-cationic Peptide-CD47 siRNA for Safety, Tolerability, and Preliminary Antitumor Activity in Patients With Advanced Malignant Solid Tumors' on May 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Metastatic solid tumor
Intervention:
25µg dose group:Subjects will receive the 25µg NCP-CD47 siRNA formulation injection for a total of 5 doses, administered at 1-week intervals
50µg dose group:Subjects will receive the 50µg NCP-CD47 siRNA formulation injection for a total of 5 doses, administ...